QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Benidipine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.025 – 2.5 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Bevacizumab (ADA) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.01 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | MSD |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Bevacizumab (PK) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 250 – 3,000 ng/mL |
| Sample Volume: | 0.03 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Bicalutamide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Bilastine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 600 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antihistamine |
| Classification: | Drug Assays |
Bisoprolol (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 100 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Bisoprolol (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 30 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Bortezomib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 500 ng/mLq |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Bosentan
Sitaxsentan (Matrix: Human Plasma)
Sitaxsentan (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 5,000 ng/mL10 – 10,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Bosutinib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 60 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Brexpiprazole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 80 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antipsychotic |
| Classification: | Drug Assays |
Bromocriptine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 4 – 1000 pg/mL |
| Sample Volume: | 0.6 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Parkinson’s Disease |
| Classification: | Drug Assays |
Budesonide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 to 5,000 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiinflammatory |
| Classification: | Drug Assays |
Bupivacaine
Dexamethasone
Lidocaine (Matrix: Dog Plasma)
Dexamethasone
Lidocaine (Matrix: Dog Plasma)
| Matrix: | Dog Plasma |
| Assay Range: | 5 – 600 ng/mL 0.1 – 50 ng/mL 5 – 600 ng/mL |
| Sample Volume: | 0.15 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Buprenorphine
Norbuprenorphine (Matrix: Human Plasma)
Norbuprenorphine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 5,000 pg/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic Analgesic |
| Classification: | Drug Assays |
Bupropion (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 200 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Bupropion
Hydroxy Bupropion (Matrix: Human Plasma)
Hydroxy Bupropion (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 200 ng/mL1 – 800 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Bupropion
Hydroxy bupropion
Erythrohydrobupropion
Threohydrobupropion (Matrix: Human Plasma)
Hydroxy bupropion
Erythrohydrobupropion
Threohydrobupropion (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 500 ng/mL2.5 – 1,250 ng/mL1 – 265 ng/mL3 – 800 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
c-Met / Hepatocyte Growth Factor Receptor 1 (HGF-R1) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1.56 – 25 ng/mL |
| Sample Volume: | 0.200 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
C-peptide (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 115 – 4,250 pmol/L |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
C-reactive protein (CRP) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.781 – 50.0 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Cabozantinib (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 1 to 1,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | NA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Caffeine
1,7-Dimethylxanthine (Matrix: Human Plasma)
1,7-Dimethylxanthine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.02 – 20 ug/mL 0.02 – 20 ug/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drug Assays |
Caffeine
1,7-Dimethylxanthine (Matrix: Human Plasma)
1,7-Dimethylxanthine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.02 – 20 ug/mL 0.02 – 20 ug/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drug Assays |
Caffeine
Paraxanthine
1-Methylxanthine
AAMU
1-Methyluric Acid
1,7-Dimethyluric Acid (Matrix: Human Urine)
Paraxanthine
1-Methylxanthine
AAMU
1-Methyluric Acid
1,7-Dimethyluric Acid (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 0.02 – 10 ug/mL 0.05 – 25 ug/mL 0.05 – 25 ug/mL 0.05 – 25 ug/mL 0.1 – 50 ug/mL 0.1 – 50 ug/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | NA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
